Triple
T17972802
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Flemming Ørnskov |
E449388
|
entity |
| Predicate | employer |
P7
|
FINISHED |
| Object | Shire plc |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Shire plc | Statement: [Flemming Ørnskov, employer, Shire plc]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Shire plc Context triple: [Flemming Ørnskov, employer, Shire plc]
-
A.
Shire
The Shire is a peaceful, rural region in J.R.R. Tolkien's Middle-earth, inhabited primarily by hobbits and known for its pastoral beauty and simple, agrarian lifestyle.
-
B.
Shire
Shire is a town in Ethiopia’s northern Tigray Region, known as a local administrative and commercial center and for its proximity to historic sites such as Axum.
-
C.
AstraZeneca
AstraZeneca is a global biopharmaceutical company known for researching, developing, and manufacturing prescription medicines across areas such as oncology, cardiovascular, respiratory, and immunology.
-
D.
Boehringer Ingelheim
Boehringer Ingelheim is a major German research-driven pharmaceutical company known for developing prescription medicines, animal health products, and biopharmaceuticals worldwide.
-
E.
Novartis
Novartis is a global Swiss-based pharmaceutical company known for developing innovative medicines across a wide range of therapeutic areas.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Shire plc Target entity description: Shire plc was a global biopharmaceutical company, originally based in the UK and later acquired by Takeda, known for developing treatments for rare diseases and specialty conditions.
-
A.
Shire
The Shire is a peaceful, rural region in J.R.R. Tolkien's Middle-earth, inhabited primarily by hobbits and known for its pastoral beauty and simple, agrarian lifestyle.
-
B.
Shire
Shire is a town in Ethiopia’s northern Tigray Region, known as a local administrative and commercial center and for its proximity to historic sites such as Axum.
-
C.
AstraZeneca
AstraZeneca is a global biopharmaceutical company known for researching, developing, and manufacturing prescription medicines across areas such as oncology, cardiovascular, respiratory, and immunology.
-
D.
Boehringer Ingelheim
Boehringer Ingelheim is a major German research-driven pharmaceutical company known for developing prescription medicines, animal health products, and biopharmaceuticals worldwide.
-
E.
Novartis
Novartis is a global Swiss-based pharmaceutical company known for developing innovative medicines across a wide range of therapeutic areas.
- F. None of above. chosen
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d8b9f9927c8190a006110c8b996e61 |
completed | April 10, 2026, 8:51 a.m. |
| NER | Named-entity recognition | batch_69e4b1fca04481908f0dd875953fd82f |
completed | April 19, 2026, 10:44 a.m. |
Created at: April 10, 2026, 10:22 a.m.